Autopsy report · NCT01608516

Multimodal Imaging Assessment of the Inflammatory Atheromatous Plaque

“studdy stopped because of patient recruitment issues”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 14 years 3 months before it stopped.
• 20 participants planned (an estimate, not an actual count).
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 1, Phase 2

Sponsor

University of Lausanne Hospitals

Sponsor type

University, hospital or other

Conditions

Inflammation; Atheromatous Plaques; Carotid Artery Diseases

Interventions

68Ga-NODAGA-RGD PET/CT

Participants

20 (planned, not actual)

Sites

1

Countries

Switzerland

Trials that died the same way

• Clinical Trials to Assess Safety and Efficacy of DWRX2003 Combination With Remdesivir in Moderate to Severe COVID-19 Patients.
  “Study stopped due to difficulties in patient recruitment” (74% match in meaning)
• Focus on Fibre Study
  “There were issues with recruitment so study was stopped” (68% match in meaning)
• All-On-4® Treatment Concept
  “The study stopped as the performance of the study showed insufficient patient recruitment.” (67% match in meaning)
• Understanding Hemophilia A and B Drug Dosage Administration Patterns
  “Study recruitment was stopped due to difficulty in enrolling the targeted number of patients on March 21, 2018. See details in Description section.” (67% match in meaning)
• Exercise to Prevent Aromatase Inhibitor Side Effects in Breast Cancer Patients
  “The study was stopped due to recruitment difficulties” (67% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.